Trentium Lifesciences Private Limited, a active private limited company, was established on 30 October 2018 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U33208GJ2018PTC105028. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Formerly known as Griffon Biometrix Private Limited. Employing 3 professional, Its leadership includes Hitesh Balvantray Shah (Director), Dharmendra N Shah (Director), Brijesh Rajendrakumar Patel (Director). Past directors included Hitesh Balvantray Shah, Siddharth Hiteshbhai Shah. It holds ₹8.00 Cr open charges and ₹9.50 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1101-1102, 11Th Floor, Empire Business Hub, Sola Science City Road, Science City,, Ahmedabad, Gujarat, 380060.
U33208GJ2018PTC105028
105028
30 October 2018
₹0.10 M
₹0.10 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Trentium Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hitesh Balvantray Shah | Director | 18 Apr 2024 | Current |
| Dharmendra N Shah | Director | 30 Oct 2018 | Current |
| Brijesh Rajendrakumar Patel | Director | 30 Oct 2018 | Current |
| Rasik Hirji Haria | Director | 30 Oct 2018 | Current |
| Chetankumar Rameshchandra Shah | Director | 30 Oct 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 21 Apr 2024 | Past |
| Pramod Abcsdd | Director | 17 Nov 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Trentium Lifesciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.69% increase. The company also saw a slight decrease in profitability, with a 9.71% decrease in profit. The company's net worth Soared by an impressive increase of 52.46%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Trentium Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹80,000,000.00
₹9,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Sep 2022 | Others | ₹8.00 Cr | Open |
| 17 Feb 2025 | Standard Chartered Bank | ₹9.50 M | Satisfied |
Explore comprehensive loan charge details -
Trentium Lifesciences has a workforce of 3 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Trentium Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trentium Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others of Rs. 80.00 M registered on 29 Sep 2022 with Charge ID 100618744 was modified on 31 Oct 2025. was completed.
The activity Trentium Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
A charge registered on 17 Feb 2025 via Charge ID 101063437 with Standard Chartered Bank was fully satisfied on 13 Jun 2025. was recorded as a recent event.
Progress on Trentium Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.
Progress on A charge with Standard Chartered Bank amounted to Rs. 9.50 M with Charge ID 101063437 was registered on 17 Feb 2025. was documented.
Hitesh Balvantray Shah was appointed as a Director was appointed as a Director on 18 Apr 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.
The CIN of Trentium Lifesciences Private Limited is U33208GJ2018PTC105028.
Trentium Lifesciences Private Limited is headquartered at 1101-1102, 11Th Floor, Empire Business Hub, Sola Science City Road, Science City,, Ahmedabad, Gujarat, 380060.
Trentium Lifesciences Private Limited was incorporated on 30 October 2018.
The current directors of Trentium Lifesciences Private Limited are
The primary industry of Trentium Lifesciences Private Limited is Manufacturing.
Trentium Lifesciences Private Limited is unlisted.
The authorized capital of Trentium Lifesciences Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX